Assoc. Prof. Rajwa and Prof. Carroll discuss MRI-targeted biopsy and active surveillance

In "Episode 6" of the series on "Present and future of diagnostics in prostate cancer", Assoc. Prof. Pawel Rajwa (PL) speaks with Prof. Peter Carroll (US) about the shifting landscape of active surveillance for intermediate-risk prostate cancer. Traditionally reserved for low-risk cases, active surveillance is now being considered for select patients with grade group 2 disease - especially when diagnosed through advanced techniques like MRI-targeted biopsy. Prof. Carroll explains how MRI has ...